NOTICE OF INTENT Ingenuity Pathway Analysis (IPA) Software Suite

The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the Walter Reed Army Institute of Research (WRAIR) intends to negotiate solely (as prescribed in FAR 13.106(b)(1)(i)) with Qiagen, 19300 Germantown Road, Germantown, MD 20874for the procurement of Ingenuity Pathway Analysis (IPA) Software Suite for genomics, transcriptomics, epigenomics and metabolomics.

The North American Industry Classification System (NAICS) for this requirement is 541511 and the size standard is $27.5M.

This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing.  Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above.  A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Ms. Flodean Billings at flodean.p.billings.civ@health.mil.

Interested concerns must identify their capability in writing to the above e-mail address or by mail to the address listed below no later than 10:00AM ET, August 24, 2023.

Contracting Office Address:
US Army Medical Research Acquisition Activity, ATTN: FCMR-ACO-AA, 820 Chandler Street, Frederick, MD 21702-5014

Point of Contact:
Flodean Billings

301-619-2648

Flodean.p.billings.civ@health.mil